Key Takeaways
- The NIH awarded a $38.5 million grant for the Developmental Genotype-Tissue Expression Project (dGTEx) to create a database of healthy pediatric tissue.
- Data from dGTEx will contribute to the Human Cell Atlas, enhancing understanding of pediatric development and disease.
- Deanne Taylor, a key figure in the project, emphasizes the need for a holistic view of pediatric development across various organ systems.
Establishing a Pediatric Tissue Database
In 2021, the National Institutes of Health (NIH) funded a significant initiative named the Developmental Genotype-Tissue Expression Project (dGTEx) with a $38.5 million grant. This project aims to build the first comprehensive database of healthy pediatric tissue. The process involves collecting samples from otherwise healthy children who have passed away, with parental consent for donation. The aim is to map the gene expression across major organ systems in children, creating a foundational database that will aid research into normal development, disease processes, and treatment efficacy.
The dGTEx team meticulously curates details about each tissue sample, including family history and other relevant information. Analysis of the samples is conducted by a separate group, after which all data is consolidated into a comprehensive resource for researchers. This initiative represents a critical first step in enhancing the understanding of various biological phenomena in pediatric health.
Eventually, the data collected by dGTEx will be integrated into the Human Cell Atlas, which recently expanded to include a pediatric section thanks to contributions from Deanne Taylor and other coauthors from a 2019 paper. Taylor plays a pivotal role in collecting and organizing vast amounts of data for the dGTEx project, while also helping to unify diverse research efforts within the Human Cell Atlas. Her colleagues commend her for emphasizing the need for a broader understanding of pediatric development rather than focusing solely on individual organ systems.
A Unique Career Path
Deanne Taylor describes her career trajectory as a “random walk,” driven by a passion for understanding biological mechanisms, influenced by undiagnosed autism and ADHD. She began reading her mother’s medical texts at age five and delved into physics books by twelve. Taylor earned her PhD in biophysics in 2001 and shifted her focus to data handling in rare-disease research during a postdoctoral position at Pfizer. She later transitioned into reproductive medicine, developing early computer programs to screen embryos for chromosomal disorders—many of which are still used today.
Even with this varied career path, Taylor’s mission has remained consistent: to understand why similar genetic diseases affect individuals differently. She questions how two people with the same gene variant can experience vastly different health outcomes. The combined data from the Human Cell Atlas, including contributions from dGTEx, has the potential to uncover insights into these disparities.
The Human Cell Atlas is viewed as an extension of the Human Genome Project, which concluded in 2003. While the Genome Project linked specific genes to diseases, it left gaps concerning how those genes function in various contexts throughout the body. The Human Cell Atlas aims to fill this void, providing deeper insights that could lead to improved understanding and treatments for pediatric diseases. By compiling and analyzing diverse data from projects like dGTEx, the goal is to enrich our understanding of pediatric health and development significantly.
The content above is a summary. For more details, see the source article.